DD281385A5 - Verfahren zur herstellung von einem 1,3-dioxynalkansaeurederivat - Google Patents

Verfahren zur herstellung von einem 1,3-dioxynalkansaeurederivat Download PDF

Info

Publication number
DD281385A5
DD281385A5 DD88315013A DD31501388A DD281385A5 DD 281385 A5 DD281385 A5 DD 281385A5 DD 88315013 A DD88315013 A DD 88315013A DD 31501388 A DD31501388 A DD 31501388A DD 281385 A5 DD281385 A5 DD 281385A5
Authority
DD
German Democratic Republic
Prior art keywords
formula
acid
compound
ether
mixture
Prior art date
Application number
DD88315013A
Other languages
German (de)
English (en)
Inventor
Andrew G Brewster
George R Brown
Reginald Jessup
Michael J Smithers
Original Assignee
��������@��������@����������@���k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ��������@��������@����������@���k�� filed Critical ��������@��������@����������@���k��
Publication of DD281385A5 publication Critical patent/DD281385A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
DD88315013A 1987-04-24 1988-04-22 Verfahren zur herstellung von einem 1,3-dioxynalkansaeurederivat DD281385A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878709794A GB8709794D0 (en) 1987-04-24 1987-04-24 Heterocyclic acids

Publications (1)

Publication Number Publication Date
DD281385A5 true DD281385A5 (de) 1990-08-08

Family

ID=10616328

Family Applications (1)

Application Number Title Priority Date Filing Date
DD88315013A DD281385A5 (de) 1987-04-24 1988-04-22 Verfahren zur herstellung von einem 1,3-dioxynalkansaeurederivat

Country Status (21)

Country Link
US (1) US4921866A (ja)
EP (1) EP0288279B1 (ja)
JP (1) JP2620298B2 (ja)
KR (1) KR880012583A (ja)
CN (1) CN1015893B (ja)
AU (1) AU609466B2 (ja)
CA (1) CA1312084C (ja)
DD (1) DD281385A5 (ja)
DE (1) DE3874394T2 (ja)
DK (1) DK217388A (ja)
FI (1) FI881829A (ja)
GB (2) GB8709794D0 (ja)
HU (1) HU204522B (ja)
IL (1) IL86066A (ja)
MY (1) MY103368A (ja)
NO (1) NO171211C (ja)
NZ (1) NZ224345A (ja)
PL (1) PL272024A1 (ja)
PT (1) PT87301B (ja)
ZA (1) ZA882528B (ja)
ZW (1) ZW3888A1 (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8901201D0 (en) * 1988-02-16 1989-03-15 Ici Plc Pyridine derivatives
US5248780A (en) * 1988-02-16 1993-09-28 Imperial Chemical Industries, Plc Pyridyl substituted alkenoic acid derivatives
IE81170B1 (en) * 1988-10-21 2000-05-31 Zeneca Ltd Pyridine derivatives
DE4018260A1 (de) * 1990-06-07 1991-12-12 Basf Ag Derivate des (beta)-picolins und diese enthaltende pflanzenschutzmittel
GB9021571D0 (en) * 1990-10-04 1990-11-21 Ici Plc Heterocyclic acids
CA2676439A1 (en) * 2007-01-18 2008-07-24 Evolva Sa Substituted 1,3-dioxanes and their uses
DE102007010077B4 (de) 2007-02-28 2010-04-08 RUHR-UNIVERSITäT BOCHUM [1,3]-Dioxane zur Modulation von GABAa-Rezeptoren
EP4190308A1 (de) 2021-12-06 2023-06-07 Marome GmbH Schlafduft sowie herstellung und verwendung von diesem

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8310407D0 (en) * 1982-05-12 1983-05-25 Ici Plc 1 3 - dioxan -5- ylalkenoic acids
GB8330120D0 (en) * 1983-11-11 1983-12-21 Ici Plc Chemical process
GB8511890D0 (en) * 1985-05-10 1985-06-19 Ici Plc Benzene derivatives
EP0201352B1 (en) * 1985-05-10 1992-06-24 Imperial Chemical Industries Plc Alkene derivatives
GB8511896D0 (en) * 1985-05-10 1985-06-19 Ici Plc Alkenes
GB8901201D0 (en) * 1988-02-16 1989-03-15 Ici Plc Pyridine derivatives

Also Published As

Publication number Publication date
US4921866A (en) 1990-05-01
JP2620298B2 (ja) 1997-06-11
EP0288279A2 (en) 1988-10-26
DK217388D0 (da) 1988-04-21
ZA882528B (en) 1988-10-24
IL86066A (en) 1992-11-15
GB8709794D0 (en) 1987-05-28
NO881768D0 (no) 1988-04-22
JPS63280082A (ja) 1988-11-17
NZ224345A (en) 1991-07-26
DE3874394D1 (en) 1992-10-15
HU204522B (en) 1992-01-28
EP0288279A3 (en) 1990-05-30
KR880012583A (ko) 1988-11-28
FI881829A (fi) 1988-10-25
PT87301B (pt) 1992-08-31
ZW3888A1 (en) 1989-11-22
NO171211B (no) 1992-11-02
NO881768L (no) 1988-10-25
NO171211C (no) 1993-02-10
FI881829A0 (fi) 1988-04-19
CN88102356A (zh) 1988-12-28
MY103368A (en) 1993-06-30
AU609466B2 (en) 1991-05-02
AU1476188A (en) 1988-10-27
CN1015893B (zh) 1992-03-18
IL86066A0 (en) 1988-09-30
CA1312084C (en) 1992-12-29
PT87301A (pt) 1988-05-01
HUT50157A (en) 1989-12-28
DK217388A (da) 1988-10-25
PL272024A1 (en) 1989-01-23
GB8808338D0 (en) 1988-05-11
EP0288279B1 (en) 1992-09-09
DE3874394T2 (de) 1993-02-25

Similar Documents

Publication Publication Date Title
EP0546388B1 (de) Azaheterocyclylmethyl-chromane als Wirkstoffe zur Behandlung von Erkrankungen des Zentralnervensystems
EP1080086B1 (de) Dihydropyrimidine
DD300434A5 (de) Heterozyklische derivate
DE60128912T9 (de) Pyridoxin- und pyridoxalanaloga als cardiovasculäre therapeutika
EP0934311A2 (de) Neue heterocyclylmethyl-substituierte pyrazolderivate und ihre verwendung in der behandlung von herz-kreislauf-erkrankungen
DD219769A5 (de) Verfahren zur herstellung von 1,3-dioxan-5-yl-alkansaeure-derivaten
DE3200304A1 (de) 3-aminopropoxyaryl-derivate, ihre herstellung und sie enthaltende arzneimittel
EP0603649A1 (de) Substituierte 4-Phenyl-pyridone und 4-Phenyl-2-alkoxypyridine als HMG-CoA-Reductase-Inhitoren
DE2940833A1 (de) 2-methyl-dihydropyridin-verbindung, verfahren zu ihrer herstellung und sie enthaltendes pharmazeutisches mittel
DD281385A5 (de) Verfahren zur herstellung von einem 1,3-dioxynalkansaeurederivat
US5011847A (en) 2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists
US4937242A (en) 1,4-dihydropyridine derivatives and pharmaceutical composition thereof
EP0473024A1 (de) Heterocyclisch substituierte Cycloalkano[b]-indolsulfonamide
EP0546389B1 (de) Piperidylmethyl substituierte Chromanderivate als Wirkstoffe zur Behandlung von Erkrankungen des Zentralnervensystems
JPS60214778A (ja) Ν置換３，４−ジヒドロピリミジン誘導体ならびにその製造法および用途
EP0749970B1 (de) Benzisothiazolyl-substituierte Aminomethylchromane
DD251749A5 (de) Verfahren zur herstellung von 2,4-diphenyl-1,3-dioxian-derivaten
EP0539803B1 (de) Triazaspirodecanon-Methyl-Chromane zur Bekämpfung von Erkrankungen des Zentralnervensystems
US4992441A (en) 1-[[5-[[4-substituted-1-piperazinyl]methyl]-pyrrol-2-yl or furan-2-yl]methyl-2-piperidinones useful in treating schizophrenia
DE2549568C3 (de) 2,6-Dimethyl-3-methoxycarbonyl-4- (2'-nitrophenyl)-1,4-dihydropyridin-5- carbonsäureisobutylester, mehrere Verfahren zu seiner Herstellung sowie ihn enthaltende Arzneimittel
DE60226225T2 (de) Phtalazine derivate mit angiogenesis inhibierender wirkung
EP0586405B1 (de) NEUE IN 4-STELLUNG DURCH ARYL ODER N-HETEROARYL SUBSTITUIERTE 2H-BENZO[b]PYRAN-DERIVATE, VERFAHREN ZU IHRER HERSTELLUNG UND IHRE VERWENDUNG SOWIE DIE VERBINDUNGEN ENTHALTENDE ZUBEREITUNGEN
JP2640245B2 (ja) １，４−ジヒドロピリジン誘導体
DD235867A5 (de) Verfahren zur herstellung von 1,4-dihydropyridinen
DE3736687A1 (de) 2-substituierte 1,4-dihydropyridinderivate

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee